Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?(Front. Immunol., (2022), 13, (921483), 10.3389/fimmu.2022.921483)

José M. Pérez de la Lastra; Uttpal Anand; Sergio González-Acosta; Manuel R. López; Abhijit Dey; Elza Bontempi; Antonio Morales delaNuez

doi:10.3389/fimmu.2024.1365827

Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?(Front. Immunol., (2022), 13, (921483), 10.3389/fimmu.2022.921483)

José M. Pérez de la Lastra
, Uttpal Anand
, Sergio González-Acosta
, Manuel R. López
, Abhijit Dey
, Elza Bontempi
, Antonio Morales delaNuez

Research output: Contribution to journal › Comment/debate

Abstract

In the published article, there was an error in the affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel”, it should be “CytoGene Research & Development LLP, Uttar Pradesh, India”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original language	English
Article number	1365827
Journal	Frontiers in Immunology
Volume	15
DOIs	https://doi.org/10.3389/fimmu.2024.1365827
State	Published - 1 Jan 2024
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

SARS-CoV-2
antibiotic discovery
antibiotic resistance
antimicrobial peptides
environmental contamination
global health
one health approach
vaccination

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.3389/fimmu.2024.1365827

Fingerprint

Dive into the research topics of 'Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?(Front. Immunol., (2022), 13, (921483), 10.3389/fimmu.2022.921483)'. Together they form a unique fingerprint.

Cite this

Pérez de la Lastra, J. M., Anand, U., González-Acosta, S., López, M. R., Dey, A., Bontempi, E., & delaNuez, A. M. (2024). Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?(Front. Immunol., (2022), 13, (921483), 10.3389/fimmu.2022.921483). Frontiers in Immunology, 15, Article 1365827. https://doi.org/10.3389/fimmu.2024.1365827

@article{444bb2605a84491b8efb430d5499a398,

title = "Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?(Front. Immunol., (2022), 13, (921483), 10.3389/fimmu.2022.921483)",

abstract = "In the published article, there was an error in the affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel”, it should be “CytoGene Research \& Development LLP, Uttar Pradesh, India”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.",

keywords = "SARS-CoV-2, antibiotic discovery, antibiotic resistance, antimicrobial peptides, environmental contamination, global health, one health approach, vaccination",

author = "\{P{\'e}rez de la Lastra\}, \{Jos{\'e} M.\} and Uttpal Anand and Sergio Gonz{\'a}lez-Acosta and L{\'o}pez, \{Manuel R.\} and Abhijit Dey and Elza Bontempi and delaNuez, \{Antonio Morales\}",

note = "Publisher Copyright: Copyright {\textcopyright} 2024 P{\'e}rez de la Lastra, Anand, Gonz{\'a}lez-Acosta, L{\'o}pez, Dey, Bontempi and delaNuez.",

year = "2024",

month = jan,

day = "1",

doi = "10.3389/fimmu.2024.1365827",

language = "English",

volume = "15",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media SA",

}

Pérez de la Lastra, JM, Anand, U, González-Acosta, S, López, MR, Dey, A, Bontempi, E & delaNuez, AM 2024, 'Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?(Front. Immunol., (2022), 13, (921483), 10.3389/fimmu.2022.921483)', Frontiers in Immunology, vol. 15, 1365827. https://doi.org/10.3389/fimmu.2024.1365827

Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?(Front. Immunol., (2022), 13, (921483), 10.3389/fimmu.2022.921483). / Pérez de la Lastra, José M.; Anand, Uttpal; González-Acosta, Sergio et al.
In: Frontiers in Immunology, Vol. 15, 1365827, 01.01.2024.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum

T2 - Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?(Front. Immunol., (2022), 13, (921483), 10.3389/fimmu.2022.921483)

AU - Pérez de la Lastra, José M.

AU - Anand, Uttpal

AU - González-Acosta, Sergio

AU - López, Manuel R.

AU - Dey, Abhijit

AU - Bontempi, Elza

AU - delaNuez, Antonio Morales

PY - 2024/1/1

Y1 - 2024/1/1

N2 - In the published article, there was an error in the affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel”, it should be “CytoGene Research & Development LLP, Uttar Pradesh, India”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

AB - In the published article, there was an error in the affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel”, it should be “CytoGene Research & Development LLP, Uttar Pradesh, India”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

KW - SARS-CoV-2

KW - antibiotic discovery

KW - antibiotic resistance

KW - antimicrobial peptides

KW - environmental contamination

KW - global health

KW - one health approach

KW - vaccination

UR - https://www.scopus.com/pages/publications/85184478500

U2 - 10.3389/fimmu.2024.1365827

DO - 10.3389/fimmu.2024.1365827

M3 - Comment/debate

C2 - 38343533

AN - SCOPUS:85184478500

SN - 1664-3224

VL - 15

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 1365827

ER -

Pérez de la Lastra JM, Anand U, González-Acosta S, López MR, Dey A, Bontempi E et al. Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?(Front. Immunol., (2022), 13, (921483), 10.3389/fimmu.2022.921483). Frontiers in Immunology. 2024 Jan 1;15:1365827. doi: 10.3389/fimmu.2024.1365827

Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?(Front. Immunol., (2022), 13, (921483), 10.3389/fimmu.2022.921483)

Abstract

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this